DESCRIPTIVE ANALYSIS OF PATIENTS WITH MALIGNANT OVARIAN NEOPLASMS APPROACHED BY THE ONCOLOGICAL SURGERY TEAM AT HOSPITAL SANTA RITA DE CÁSSIA

• DOI: 10.22533/at.ed.15931123100210

• Palavras-chave: Surgery. Ovary cancer. Cytorreduction. Staging.

• Keywords: Surgery. Ovary cancer. Cytorreduction. Staging.

• Abstract:

  Introduction: In developed countries, ovarian cancer is the leading cause of death from gynecological tumors. Diagnoses occur in more advanced stages. Primary debulking surgery followed by chemotherapy is the treatment of choice for most cases, but the determining factor for survival is performing optimal debulking. Goal:  To evaluate the surgeries performed in the service and describe the epidemiological profile.Materials and methods: The study is retrospective, descriptive and quantitative, carried out through the analysis of data collected at Hospital Santa Rita de Cássia. Patients with ovarian malignancy who underwent surgical treatment by the oncology surgery team from January 2016 to December 2020 at Hospital Santa Rita de Cássia were evaluated. Results: The sample consisted of 79 patients, 62 were excluded, leaving a total of 17 patients. We identified the predominance of serous tumors. Of the patients in the sample, 23.5% underwent surgeries considered ideal (complete and optimal) and 41.2% underwent biopsy and were referred to neoadjuvant therapy. The sample comprised 59.3% of patients in more advanced stages (IIIC and IV). Recurrence occurred in 70% of cases. 41% of patients evolved to death. Conclusion: The study evaluated the surgeries performed by classifying and identifying the frequency of each one. The low ratio of ideal debulking may reflect the greater number of patients with advanced disease at the time of diagnosis. We can conclude that early diagnosis followed by adequate surgical treatment, when feasible, is essential for a better prognosis for these patients.